In fact, in vitro studies evidenced that ZEB1 downmodulation, and the concomitant upregulation of the inhibitory SMAD7, could increase the resistance of ATLL cell lines to TGF-β1-mediated growth arrest [54]. The gene discussed is SMAD7; the disease is adult T-cell leukemia/lymphoma.